Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SVP, Bioservices

EVP, Quality & Ethics, and CPL

SVP, Products Business

EVP, Chief Financial Officer

EVP, Ext Aff, GC, Corp Sec

EVP, Business Operations

President and CEO

Chairman

EVP, Chief Strat & Dev Officer

EVP, Chief HR Officer

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. Its products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; public health crises; and acute, emergency, and community care. The company offers ACAM2000, a smallpox vaccine; Anthrasil to for inhalational anthrax; Botulism Antitoxin Heptavalent to treat botulinum disease; BioThrax, an anthrax vaccine; Ebanga, a monoclonal antibody to treat infection caused by Zaire ebolavirus; raxibacumab injection for the treatment of inhalational anthrax; reactive skin decontamination lotion kits; TEMBEXA for the treatment of human smallpox disease; Trobigard, an auto-injector atropine sulfate and obidoxime chloride auto-injector for the emergency treatment of known or suspected exposure to nerve agents; and vaccinia immune globulin intravenous that addresses complications from smallpox vaccine. It also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, the company is developing AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; EBS-LASV; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accident...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-07	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Bioservices
2024-04-07	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Quality & Ethics, and CPL
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Bioservices
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Products Business
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Quality & Ethics, and CPL
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Financial Officer
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Ext Aff, GC, Corp Sec
2024-02-29	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Financial Officer
2024-02-29	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Products Business
2024-02-29	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Ext Aff, GC, Corp Sec
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Products Business
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Ext Aff, GC, Corp Sec
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Financial Officer
2024-02-21	Premium	back to issuer	Premium	Premium	Premium	EVP, Chief Financial Officer
2023-11-13	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Products Business
2023-11-11	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Bioservices
2023-11-11	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Ext Aff, GC, Corp Sec
2023-10-03	Premium	acquired	Premium	Premium	Premium	-
2023-10-03	Premium	acquired	Premium	Premium	Premium	-
2023-07-08	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Products Business
2023-06-09	Premium	acquired	Premium	Premium	Premium	EVP, Business Operations
2023-06-09	Premium	acquired	Premium	Premium	Premium	SVP, Products Business
2023-06-09	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-09	Premium	acquired	Premium	Premium	Premium	EVP, Chief Financial Officer
2023-06-09	Premium	acquired	Premium	Premium	Premium	EVP, Ext Aff, GC, Corp Sec

EBS - Emergent BioSolutions Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for EBS